Does UPADACITINIB Cause Inflammation? 764 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 764 reports of Inflammation have been filed in association with UPADACITINIB (Rinvoq). This represents 1.2% of all adverse event reports for UPADACITINIB.
764
Reports of Inflammation with UPADACITINIB
1.2%
of all UPADACITINIB reports
12
Deaths
192
Hospitalizations
How Dangerous Is Inflammation From UPADACITINIB?
Of the 764 reports, 12 (1.6%) resulted in death, 192 (25.1%) required hospitalization, and 16 (2.1%) were considered life-threatening.
Is Inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 764 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Inflammation?
ADALIMUMAB (7,754)
METHOTREXATE (5,055)
ETANERCEPT (4,459)
RITUXIMAB (3,540)
SECUKINUMAB (3,515)
INFLIXIMAB (3,448)
TOCILIZUMAB (3,371)
ABATACEPT (3,284)
TOFACITINIB (3,241)
LEFLUNOMIDE (3,067)
Which UPADACITINIB Alternatives Have Lower Inflammation Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL